NEW YORK PSYCHOANALYTIC SOCIETY & INSTITUTE:
Extension Program
247 East 82nd St., between 2nd & 3rd, NY, NY 10028
212-879-6900
www.psychoanalysis.org
www.nypsi.org
SHARED THERAPY: THE COLLABORATION BETWEEN PSYCHOTHERAPIST & PSYCHOPHARMACOLOGIST
Charles A. Murkofsky, M.D.
Tuesdays, 7:30 – 8:45 pm, March 19, April 2, & 9, 2013, 3 sessions, Fee: $60
Registration & Info: www.nypsi.org
under Continuing Education & Research
This seminar focuses on the issues of collaborative treatment: Navigating the interface, dealing with rivalry, understanding therapeutic effects of psychological and pharmacological therapies, identification of appropriate cases for pharmacologic referral, discussion of the benefit/detriment issue of pharmacotherapy on psychotherapy. The syndromes most frequently treated with pharmacotherapy will be reviewed. Participants are invited to bring illustrative case material.
Dr. Murkofsky is a member of NYPSI. He is on the faculty of Mt. Sinai and Albert Einstein Medical Schools, a Fellow of the Academy of Eating Disorders, a Fellow of New York Academy of Medicine, and a Founding Member of the National Eating Disorders Association. He is in private practice.
The Extension Program welcomes mental health professionals, trainees in fields of psychiatry, psychology, and social work, and any members of the community who are interested in psychoanalytic principles.
Educational Objectives: After taking this course, participants will be able to:
1. identify the potential problematic interface issues involved when sharing therapy: e.g. rivalry, dominance struggles, transference splitting, fee imbalance, etc.
2. identify the potential beneficial interface issues in shared therapy, e.g. additional professional assessment, collegial support, patients’ enhanced sense f being cared for, reduced risk management exposure, broadening clinical perspective bilaterally, etc.
3. identify psychotherapy cases appropriate for pharmacological treatment, as well as the reverse.
4. identify target symptoms and syndromes most frequently and usefully treated with medication.
5. identify the medications used to achieve the therapeutic goals.
Information regarding CME credits for physicians:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Psychoanalytic Association and the New York Psychoanalytic Society and Institute. The American Psychoanalytic Association is accredited by the ACCME to provide continuing medical education for physicians.
The American Psychoanalytic Association designates this Live Activity for a maximum of [3.75] AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
IMPORTANT DISCLOSURE INFORMATION FOR ALL LEARNERS: None of the planners and presenters of this CME program have any relevant financial relationships to disclose.
Information regarding CE credits for psychologists:
Who Should Attend: Mental health professionals (psychiatrists, psychologists, social workers, and licensed psychotherapists).
APA-approved CE Credits:
Psychologists: New York Psychoanalytic Society & Institute is approved by the American Psychological Association (APA) to sponsor continuing education programs for psychologists. NYPSI maintains responsibility for this program and its content. APA-approved CE credits are granted to participants with documented attendance and completed evaluation forms. Upon receipt of the completed evaluation form, we will send you via email a PDF of your CE credits.
Persons with disabilities: The building is wheelchair accessible and has an elevator. Please notify the registrar in advance if you require accommodations.
DISCLOSURE: None of the planners or presenters of this CE program has any relevant financial relationships to disclose.
For information about NYPSI training programs please visit us at
www.psychoanalysis.org or www.nypsi.org